Pancreatic Cancer Research

ResearcherDublin City UniversityNo recent work listed

Sandra Roche

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4363-4607; OpenAlex author ID A5080905361. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 5 papers · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Der… Co-author DOI 10.3390/life13030608↗
  2. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. Last author DOI 10.1208/s12248-022-00752-8↗
  3. DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Co-author DOI 10.1016/j.jconrel.2020.05.046↗
  4. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development. Co-author DOI 10.1038/s41598-020-59368-7↗
  5. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo. Co-author DOI 10.1097/mpa.0000000000001633↗
  6. Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion and Progression of Pancreatic Cancer. First author DOI 10.1155/2020/2951921↗
  7. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. Co-author DOI 10.3390/ijms21030962↗
  8. A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Co-author DOI 10.3390/proteomes6040045↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin M. Clynes · 7 shared papers, 2018–2023 · strength 0.75
  2. Fiona O’Neill · 6 shared papers, 2018–2023 · strength 0.62
  3. Robert M. Straubinger · 5 shared papers, 2018–2023 · strength 0.54
  4. Kevin C. Conlon · 4 shared papers, 2018–2023 · strength 0.40
  5. Paula Meleady · 3 shared papers, 2018–2023 · strength 0.31
  6. Taylor J. Allen-Coyle · 2 shared papers, 2022–2023 · strength 0.30
  7. Finbarr O’Sullivan · 2 shared papers, 2022–2023 · strength 0.30
  8. Ray McDermott · 2 shared papers, 2020–2023 · strength 0.23
  9. Naomi Walsh · 2 shared papers, 2020 · strength 0.21
  10. Shannon R. Nelson · 2 shared papers, 2020 · strength 0.21
  11. Annemarie Larkin · 2 shared papers, 2020 · strength 0.21
  12. Orla Coleman · 2 shared papers, 2018–2020 · strength 0.17
  13. Jin Niu · 1 shared paper, 2022 · strength 0.15
  14. Michael C. Johnston · 1 shared paper, 2020 · strength 0.09
  15. Michelle K. Greene · 1 shared paper, 2020 · strength 0.09
  16. Christopher J. Scott · 1 shared paper, 2020 · strength 0.09
  17. Rozana Abdul Rahman · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.